Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat

Iranian Journal of Pharmaceutical Research

Volumn 14, Issue 4, 2015, Pages 1145-1152

  Negahdar, Feraidoon ^a   Mehdizadeha, Mehdi ^a   Joghataei, Mohammad Taghi ^a   Roghani, Mehrdad ^b   Mehraeen, Fereshteh ^a   Poorghayoomi, Ehsan ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

6 hydroxydopamine; Berberine; Parkinson s disease; Tyrosine hydroxylase

Indexed keywords

APOMORPHINE; BERBERINE; REACTIVE OXYGEN METABOLITE; TYROSINE 3 MONOOXYGENASE;

6 HYDROXYDOPAMINE INDUCED PARKINSON DISEASE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; MALE; MENTAL ROTATION TEST; MOLECULAR PATHOLOGY; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; RAT; STEREOTACTIC PROCEDURE; SUBSTANTIA NIGRA PARS COMPACTA;

EID: 84965046316     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Sedaghat R, Roghani M and Khalili M. Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model. Iran J. Pharm. Res. (2014) 13:227-34.
2. Roghani M, Niknam A, Jalali-Nadoushan MR, Kiasalari Z, Khalili M and Baluchnejadmojarad T. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism. Brain Res. Bull. (2010) 82:279-83.
3. Pyo JH, Jeong YK, Yeo S, Lee JH, Jeong MY, Kim SH, Choi YG and Lim S. Neuroprotective effect of trans-cinnamaldehyde on the 6-hydroxydopamine-induced dopaminergic injury. Biol. Pharm. Bull. (2013) 36:1928-35.
4. Tatton WG, Chalmers-Redman R, Brown D and Tatton N. Apoptosis in Parkinson›s disease: signals for neuronal degradation. Ann. Neurol. (2003) 53:S61-70.
5. Lev N, Melamed E and Offen D. Apoptosis and Parkinson›s disease. Prog. Neuropsychopharmacol. Biol. Psychiatry (2003) 27:245-50.
6. Baluchnejadmojarad T, Roghani M and Mafakheri M. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neurosci. Lett. (2010) 480:206-10.
7. Eyhani-Rad S, Mohajjel Nayebi A, Mahmoudi J, Samini M and Babapour V. Role of 5-hydroxytryptamine 1A receptors in 6-hydroxydopmaine-induced catalepsy-like immobilization in rats: a therapeutic approach for treating catalepsy of Parkinson›s disease. Iran J. Pharm. Res. (2012) 11:1175-81.
8. Ossig C and Reichmann H. Treatment of Parkinson›s disease in the advanced stage. J. Neural Transm. (2013) 120:523-9.
9. Datla KP, Zbarsky V, Rai D, Parkar S, Osakabe N, Aruoma OI and Dexter DT. Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson›s disease. J. Am. Coll. Nutr. (2007) 26:341-9.
10. Zhang Q, Qian Z, Pan L, Li H and Zhu H. Hypoxia-inducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia/ischemia. Acta Physiol. Hung. (2012) 99:311-23.
11. Kalalian-Moghaddam H, Baluchnejadmojarad T, Roghani M, Goshadrou F and Ronaghi A. Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats. Eur. J. Pharmacol. (2013) 698:259-66.
12. Durairajan SS, Liu LF, Lu JH, Chen LL, Yuan Q, Chung SK, Huang L, Li XS, Huang JD and Li M. Berberine ameliorates beta-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer›s disease transgenic mouse model. Neurobiol. Aging (2012) 33:2903-19.
13. Jia L, Liu J, Song Z, Pan X, Chen L, Cui X and Wang M. Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways. J. Pharm. Pharmacol. (2012) 64:1510-21.
14. Kwon IH, Choi HS, Shin KS, Lee BK, Lee CK, Hwang BY, Lim SC and Lee MK. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson›s disease. Neurosci. Lett. (2010) 486:29-33.
15. Bae J, Lee D, Kim YK, Gil M, Lee JY and Lee KJ. Berberine protects 6-hydroxydopamine-induced human dopaminergic neuronal cell death through the induction of heme oxygenase-1. Mol. Cells (2013) 35:151-7.
16. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates.2nded., Academic Press, San Diego (1986).
17. Chou VP, Ko N, Holman TR and Manning-Bog AB. Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson›s disease. J. Vis. Exp. (2014) 83:e50960.
18. Schober A. Classic toxin-induced animal models of Parkinson›s disease: 6-OHDA and MPTP. Cell Tissue Res. (2004) 318:215-24.
19. Schwarting RK and Huston JP. Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions. Neurotoxicology (1997) 18:689-708.
20. Jalali-Nadoushan M and Roghani M. Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism. Brain Res. (2013) 1505:68-74.
21. Foley P and Riederer P. Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson›s disease. J. Neurol. (2000) 247:II82-94.
22. Lotharius J and Brundin P. Pathogenesis of Parkinson›s disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. (2002) 3:932-42.
23. von Bohlen undHalbach O, Schober A and Krieglstein K. Genes, proteins, and neurotoxins involved in Parkinson›s disease. Prog. Neurobiol. (2004) 73:151-77.
24. Chen S and Le W. Neuroprotective therapy in Parkinson disease. Am. J. Ther. (2006) 13:445-57.
25. Zhou F, Wu JY, Sun XL, Yao HH, Ding JH and Hu G. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation. Neuropsychopharmacology (2007) 32:2570-80.
26. Miklossy J, Doudet DD, Schwab C, Yu S, McGeer EG and McGeer PL. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp. Neurol. (2006) 197:275-83.
27. Sriram K and O’Callaghan JP. Divergent roles for tumor necrosis factor-alpha in the brain. J. Neuroimmune Pharmacol. (2007) 2:140-53.
28. Wang Y. Attenuation of berberine on lipopolysaccharide-induced inflammatory and apoptosis responses in beta-cells via TLR4-independent JNK/NF-kappaB pathway. Pharm. Biol. (2013)52: 532-538.
29. Hwang CK and Chun HS. Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons. Biosci. Biotechnol. Biochem. (2012) 76:536-43.